Paul J. Clancy

This profile gathers the share dealings of Paul J. Clancy across 4 companies, led by Incyte Corp, Exact Sciences Corp and Agios Pharmaceuticals, Inc. We count 40 filings; the first trade dates from 8 February 2016 and the latest from 30 September 2026.

The open-market record consists of 1 sale worth €1.2M, with no purchase. Outside the open market, there are 34 share grants and 4 option exercises. 2026 to date brings no purchases and 1 sale.

Most recently, on 2 October 2026, the filings show a share grant worth €22k in Incyte Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.